Follow Us
  • Facebook Basic Black
  • Twitter Basic Black
  • LinkedIn Social Icon

Type 2 diabetes drug may lead to excessive acid in the blood and UTI, FDA warns

"The U.S. Food and Drug Administration (FDA) has added warnings to the labels of a specific class of type 2 diabetes medicines, after a safety review showed it may lead to having too much acid in the blood and serious urinary tract infections.

Sodium-glucose cotransporter-2, or SGLT2 inhibitors, refers to a class of prescription medicines that FDA approved to lower blood sugar in adults with type 2 diabetes. It is not, however, approved by the agency for use in patients with type 1 diabetes."

Click here to read the full article



Must Read

Awards & Honors

All Contents © Copyright Epinex Diagnostics, Inc. 2011. All Rights Reserved